Clinical correlates of CSF Aβ42 and tau in patients with mild cognitive impairment

被引:0
|
作者
Schoonenboom, NS
Visser, PJ
Van Elk, EJ
Lindeboom, J
Mulder, C
Scheltens, P
机构
[1] VU Univ Med Ctr, Alzheimer Ctr, Dept Neurol, Amsterdam, Netherlands
[2] VU Univ Med Ctr, Dept Clin Chem, Amsterdam, Netherlands
[3] VU Univ Med Ctr, Alzheimer Ctr, Dept Psychol, Amsterdam, Netherlands
关键词
D O I
10.1016/S0197-4580(04)81190-4
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:S361 / S361
页数:1
相关论文
共 50 条
  • [41] Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment
    Parnetti, Lucilla
    Chiasserini, Davide
    Eusebi, Paolo
    Giannandrea, David
    Bellomo, Gianni
    De Carlo, Claudia
    Padiglioni, Chiara
    Mastrocola, Sara
    Lisetti, Viviana
    Calabresi, Paolo
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 29 (01) : 229 - 238
  • [42] ACE activity in CSF of patients with mild cognitive impairment and Alzheimer disease
    He, M.
    Ohrui, T.
    Maruyama, M.
    Tomita, N.
    Nakayama, K.
    Higuchi, M.
    Furukawa, K.
    Arai, H.
    NEUROLOGY, 2006, 67 (07) : 1309 - 1310
  • [43] Biomarkers of Alzheimer's disease in the CSF of patients with mild cognitive impairment
    Monge-Argiles, J. A.
    Munoz-Ruiz, C.
    Pampliega-Perez, A.
    Gomez-Lopez, M. J.
    Sanchez-Paya, J.
    Rodriguez-Borja, E.
    Ruiz-Vegara, M.
    Montoya-Gutierrez, J.
    Leiva-Santana, C.
    JOURNAL OF NEUROLOGY, 2010, 257 : S166 - S166
  • [44] CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
    Mattsson, Niklas
    Zetterberg, Henrik
    Hansson, Oskar
    Andreasen, Niels
    Parnetti, Lucilla
    Jonsson, Michael
    Herukka, Sanna-Kaisa
    van der Flier, Wiesje M.
    Blankenstein, Marinus A.
    Ewers, Michael
    Rich, Kenneth
    Kaiser, Elmar
    Verbeek, Marcel
    Tsolaki, Magda
    Mulugeta, Ezra
    Rosen, Erik
    Aarsland, Dag
    Visser, Pieter Jelle
    Schroeder, Johannes
    Marcusson, Jan
    de Leon, Mony
    Hampel, Harald
    Scheltens, Philip
    Pirttilae, Tuula
    Wallin, Anders
    Jonhagen, Maria Eriksdotter
    Minthon, Lennart
    Winblad, Bengt
    Blennow, Kaj
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (04): : 385 - 393
  • [45] Tau pathology mediated the plasma biomarkers and cognitive function in patients with mild cognitive impairment
    Zhao, Lu
    Qiu, Qi
    Zhang, Shaowei
    Yan, Feng
    Li, Xia
    EXPERIMENTAL GERONTOLOGY, 2024, 195
  • [46] Patients with mild cognitive impairment and a reduced CSF Aβ1-42 protein progress rapidly to Alzheimer's disease
    Monge-Argiles, J. A.
    Sanchez-Paya, J.
    Munoz-Ruiz, C.
    Pampliega-Perez, A.
    Gomez-Lopez, M. J.
    Rodriguez Borja, E.
    Montoya-Gutierrez, J.
    Leiva-Santana, C.
    NEUROLOGIA, 2012, 27 (01): : 28 - 33
  • [47] Cognitive correlates of financial abilities in mild cognitive impairment
    Okonkwo, Ozioma C.
    Wadley, Virginia G.
    Griffith, H. Randall
    Ball, Karlene
    Marson, Daniel C.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (11) : 1745 - 1750
  • [48] CSF levels of total TAU, TAU protein phosphorylated at threonine 181 and serine 199 as predictors of Alzheimer's disease in patients with mild cognitive impairment
    Boban, M.
    Grbic, K.
    Hof, P. R.
    Sussmair, C.
    Ackl, N.
    Bader, B.
    Danek, A.
    Simic, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 95 - 95
  • [49] CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease
    Liu, Changqin
    Cholerton, Brenna
    Shi, Min
    Ginghina, Carmen
    Cain, Kevin C.
    Auinger, Peggy
    Zhang, Jing
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (03) : 271 - 276
  • [50] CSF APPsα and Phosphorylated Tau Protein Levels in Mild Cognitive Impairment and Dementia of Alzheimer's Type
    Fellgiebel, Andreas
    Kojro, Elzbieta
    Mueller, Matthias J.
    Scheurich, Armin
    Schmidt, Lutz G.
    Fahrenholz, Falk
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2009, 22 (01) : 3 - 9